Cleft Lip and Cleft Palate
Conditions
Keywords
Cleft lip and palate
Brief summary
Newborns with bilateral cleft lip/ palate will be treated pre-surgically by either nasal elevator or Grayson nasal stent in conjunction with digital nasoalveolar molding (D-NAM) appliance in order to evaluate their effect on the nasolabial esthetics.
Detailed description
The aim of this trial is to evaluate and compare the short-term effect of nasal elevator with Grayson nasal stent in conjunction with digital nasoalveolar molding appliances at 2 stages T1 (Before NAM therapy), and T2 (After NAM therapy) as regards nasolabial esthetics and maxillary arch changes. Newborns with Bilateral cleft lip/ palate will be allocated randomly into two groups: the first group will receive nasal elevator with digital nasoalveolar molding appliance while the second group will receive Grayson nasal stent with digital nasoalveolar molding appliance. The follow-up period will be 4-6 months till surgical lip closure. The nasolabial esthetics will be assessed using facial scans and 2D photographs, while changes in the maxillary arch will be assessed by digital maxillary models.
Interventions
This is a unique nasal elevator aiming to improve nasolabial esthetics in conjunction with digital nasoalveolar molding appliance when used in bilateral cleft lip and palate infants.
Nasal stent that is used in conjunction with digital nasoalveolar molding in bilateral cleft lip and palate infants
Sponsors
Study design
Eligibility
Inclusion criteria
* Non-syndromic Infants with complete BCLP infants * Infants less than 1 month of age. * Males and females. * Infants with displaced premaxilla * Patients whose parents provided written consent for the study.
Exclusion criteria
* Patients above 1 month of age. * Syndromic and systemically ill infants. * Patients with unilateral cleft lip and palate. * Incomplete Cleft lip or Simonart band (soft tissue bridge at the cleft side). * Medically compromised patients * Patien parents/guardians who will be unwilling to go through the Naso-alveolar molding (NAM) therapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Nasolabial esthetics | 4-6 months | Columellar length is to be measured in millimeters digitally using facial scans before and after Nasoalveolar Molding therapy. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Maxillary arch changes | 4-6 months | Maxillary arch changes will be assessed in millimeters using maxillary digital models. |